The additional demand was raised for disallowances related to deduction of profits and gains derived from the business of developing, maintaining, and operating the infrastructure facilities, expenditure on R&D, business or professional expenses.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/n8exAop
via IFTTT
No comments:
Post a Comment